regulatory-affairs-head

原文涵盖的主题

• Head of Regulatory Affairs
• Table of Contents
• Regulatory Strategy Workflow
• Workflow: New Product Regulatory Strategy
• Regulatory Pathway Selection Matrix
• Regulatory Strategy Document Template
• FDA Submission Workflow
• Workflow: 510(k) Submission

Regulatory strategy development, submission management, and global market access for medical device organizations. -- Regulatory Strategy Workflow FDA Submission Workflow EU MDR Submission Workflow Global Market Access Workflow Regulatory Intelligence Workflow Decision Frameworks Tools and References -- Develop regulatory strategy aligned with business objectives and product characteristics. 1. Gather product information: Intended use and indications Device classification (risk level) Technology platform Target markets and timeline 2. Identify applicable regulations per target market: FDA (US): 21 CFR Part 820, 510(k)/PMA/De Novo EU: MDR 2017/745, Notified Body requirements Other markets: Health Canada, PMDA, NMPA, TGA 3. Determine optimal regulatory pathway: Compare submission types (510(k) vs De Novo vs PMA) Assess predicate device availability Evaluate clinical evidence requirements 4. Develop regulatory timeline with milestones 5. Estimate resource requirements and budget 6. Identify regulatory risks and mitigation strategies 7. Obtain stakeholder alignment and approval 8. Validation: Strategy document approved; timeline accepted; resources allocated | Factor | 510(k) | De Novo

这里只展示节选，请以完整原文和当前要求为准。